Table of contents
Expand All Topics
Postural orthostatic tachycardia syndrome
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of postural orthostatic tachycardia syndrome are prepared by our editorial team based on guidelines from the Canadian Cardiovascular Society (CCS 2020) and the European Society of Cardiology (ESC 2020).
1
2
Screening and diagnosis
Classification and risk stratification
Diagnostic investigations
History and physical examination
As per CCS 2020 guidelines:
Elicit a detailed medical history and perform physical examination in the initial assessment of patients with suspected POTS. Recognize that this approach is sufficient for most patients to establish a diagnosis and initiate treatment.
A
Obtain HR and BP measurement in supine position for at least 5 minutes, and then in standing position for up to 10 minutes. Diagnose POTS if the orthostatic tachycardia is sustained for at least 2 consecutive recordings (separated by at least 1 minute) after the first minute.
B
More topics in this section
Laboratory tests
ECG
Echocardiography
Additional testing
Evaluation for comorbidities
Medical management
General principles
As per CCS 2020 guidelines:
Manage patients with POTS by primary care physicians for the diagnosis, appropriate exclusion of alternative diagnoses, and initial treatments.
B
Ensure collaborative multidisciplinary care including physicians and allied health professionals for patients with POTS.
B
More topics in this section
Pharmacologic therapy
Intravenous fluids
Nonpharmacologic interventions
Withdrawal of offending agents: as per CCS 2020 guidelines, withdraw any medication or substance that might exacerbate orthostatic tachycardia or orthostatic symptoms as the first therapeutic step, if possible.
B
More topics in this section
Water and salt intake
Exercise programs
Compression garments
Therapeutic procedures
Surgical interventions
Surgical correction of Chiari malformation: as per CCS 2020 guidelines, do not perform surgical decompression of Chiari malformation to alleviate primary symptoms of POTS.
D
More topics in this section
Jugular vein dilation and stenting